Michaele Armstrong, PhD, MBA

Seattle Angel Conference is a program to build new Angel Investors in the local startup ecosystems. Where accredited investors and startup founders are introduced to the world of angel investing through a guided process that includes multiple pitch events and hands-on training sessions. Teaching Angel Investing by doing Angel Investing. Results -- Startups get funded. The number of Angel Investors active in the community increases.

Seattle Angel Conference is a program to build new Angel Investors in the local startup ecosystems. Where accredited investors and startup founders are introduced to the world of angel investing through a guided process that includes multiple pitch events and hands-on training sessions. Teaching Angel Investing by doing Angel Investing. Results -- Startups get funded. The number of Angel Investors active in the community increases.

Located in the University District of Spokane, SP3NW officially launched in December 2020 to build and support a flexible infrastructure for resilient entrepreneurship that identifies, grows, and deploys emerging innovations. We support the launch of businesses by providing physical office and wet lab spaces, educational and experiential programming, executive advisement, and access to resources and advisors from the five universities and colleges, located on the U-District campus. Our Mission Through our programs, SP3NW supports WSU’s mission as a land-grant research university by connecting community to academia, entrepreneurs, innovators, funding sources, and industry mentors to advance technological solutions, launch new companies, and create living-wage jobs in the region. Our Goals 1. Translate ideas into scalable business models 2. Launch investable, successful companies 3. Contribute to a regional innovation ecosystem

At OHSU, we deliver breakthroughs for better health. Were driven by the belief that better health starts with innovations in the lab, in the classroom, at the bedside and in our communities. From cancer to Alzheimers to cardiovascular care, we collaborate every day to identify and deliver new ways to understand disease, treat illness and train the next generation of scientists and health professionals. It takes all of us - from scientists, clinicians and nurses to a top-notch professional staff. Join us.

Please follow us on LinkedIn at https://www.linkedin.com/company/predictive-oncology. Helomics® is now part of Predictive Oncology, which is headquartered in Pittsburgh, Pennsylvania, and maintains a state-of-the-art research laboratory dedicated to oncology drug discovery and a CLIA-certified clinical laboratory.

The University of Pittsburgh is a top-ranked, public institution in Pennsylvania and a member of the Association of American Universities of leading research universities. With our discoveries, we are recognized as one of the most innovative universities in the world. We invent the paths of the future and forge ahead. Pitt is a member of the Association of American Universities (AAU), which comprises 62 preeminent doctorate-granting research institutions in North America.